Details for New Drug Application (NDA): 050778
✉ Email this page to a colleague
The generic ingredient in ELLENCE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.
Summary for 050778
Tradename: | ELLENCE |
Applicant: | Pfizer Inc |
Ingredient: | epirubicin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 050778
Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 050778
Suppliers and Packaging for NDA: 050778
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ELLENCE | epirubicin hydrochloride | INJECTABLE;INJECTION | 050778 | NDA | Pharmacia & Upjohn Company LLC | 0009-5091 | 0009-5091-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-5091-01) / 25 mL in 1 VIAL, SINGLE-DOSE |
ELLENCE | epirubicin hydrochloride | INJECTABLE;INJECTION | 050778 | NDA | Pharmacia & Upjohn Company LLC | 0009-5093 | 0009-5093-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-5093-01) / 100 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML (2MG/ML) | ||||
Approval Date: | Sep 15, 1999 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/25ML (2MG/ML) | ||||
Approval Date: | Sep 15, 1999 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription